NCT04155359View on ClinicalTrials.gov

Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria Patients

Active, not recruitingOBSERVATIONAL
Enrollment

444

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Bladder Cancer
Trial Locations (1)

11735

Integrated Medical Professionals, Farmingdale

All Listed Sponsors
lead

miR Scientific LLC

INDUSTRY